Data updated: Mar 29, 2026

FALCON PHARMS

Immunology

Pharma

FALCON PHARMS is a pharmaceutical company focused on Immunology.

1994

Since

2

Drugs

-

Trials

57

Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues ProEarly access

Loading...

Revenue Over Time ProEarly access

Loading...

Recent Activity

DICLOFENAC SODIUM 2025-12-31

DICLOFENAC SODIUM 2025-11-05

DICLOFENAC SODIUM 2025-09-26

DICLOFENAC SODIUM 2025-05-21

DICLOFENAC SODIUM 2025-04-09

DICLOFENAC SODIUM 2024-11-21

DICLOFENAC SODIUM 2024-11-21

DICLOFENAC SODIUM 2024-11-21

SEC Filings ProEarly access

Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Immunology 100%

1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones ProEarly access

Loading...

Patent Cliff ProEarly access

Loading...

Competitors by Therapeutic Area

Pfizer big-pharma

Novartis big-pharma

Merck big-pharma

AbbVie big-pharma

Johnson & Johnson big-pharma